Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ACTIVASE RT-PA 100 ML

WATER : 100 ML ALTEPLASE : 100 MG · DIN 02147440 · HOFFMANN-LA ROCHE LIMITED

Health Canada status: MARKETED

What is ACTIVASE RT-PA?

ACTIVASE RT-PA 100 ML contains WATER : 100 ML ALTEPLASE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02147440, held by HOFFMANN-LA ROCHE LIMITED, supplied as POWDER FOR SOLUTION ; LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 31-Dec-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ACTIVASE RT-PA used for?

ACTIVASE rt - PA (alteplase for injection) is indicated for intravenous use in adults for: 1) the lysis of suspected occlusive coronary artery thrombi associated with evolving transmural myocardial infarction; and 2) the reduction of mortality associated with acute myocardial infarction (AMI), the improvement of ventricular function following AMI and the reduction in the incidence of congestive heart failure. Treatment should be initiated as soon as possible after the onset of acute myocardial symptoms.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02147440
Brand nameACTIVASE RT-PA
Generic / active ingredientWATER : 100 ML ALTEPLASE : 100 MG
ManufacturerHOFFMANN-LA ROCHE LIMITED
Strength100 ML
Dosage formPOWDER FOR SOLUTION ; LIQUID
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeB01AD02 ALTEPLASE
AHFS class20:12.20
BiosimilarNo
Health Canada statusMARKETED
Status date31-Dec-1996
Original market date1996-12-31 00:00:00

How is it stored and handled?

when stored at 2 - 30 ℃

How is it supplied?

Boxes each containing one (1) vial of ACTIVASE rt - PA 50 mg and one (1) vial of Sterile Water for Injection, USP 50 mL, for preparing a sterile solution of ACTIVASE rt - PA. Boxes each containing one (1) vial of ACTIVASE rt - PA 100 mg and one (1) vial of Sterile Water for Injection, USP 100 mL, and one transfer device for preparing a sterile solution of ACTIVASE rt - PA.

What can be used instead?

Other Canadian products sharing ATC code B01AD02 ALTEPLASE. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACTIVASE RT-PA50 MGPOWDER FOR SOLUTION ; LIQUIDHOFFMANN-LA ROCHE LIMITEDMARKETEDDIN 02225689
CATHFLO2 MGPOWDER FOR SOLUTIONHOFFMANN-LA ROCHE LIMITEDMARKETEDDIN 02245859
ACTIVASE RT-PA INJ29 MPOWDER FOR SOLUTIONHOFFMANN-LA ROCHE LIMITEDCANCELLED POST MARKETDIN 00771473
LYSATEC RT - PA50 MGPOWDER FOR SOLUTIONGENENTECH INCCANCELLED POST MARKETDIN 02009285

Who else supplies ALTEPLASE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. ALTEPLASE appears in 19 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ACTIVASE RT-PA

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02147440. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.